Symposia
Child / Adolescent - School-Related Issues
Jason Jones, Ph.D.
Research Assistant professor
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Molly Davis, Ph.D. (she/her/hers)
Research Psychologist
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Karen T. G. Schwartz, Ph.D. (she/her/hers)
Research Psychologist
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Gillian Dysart, BA
Clinical Research Coordinator
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Amy So, B.S.
Graduate Student
Montclair State University
East Brunswick, New Jersey, United States
Rebecca Kanine, PhD
Pediatric Psychologist
Children's Hospital of Chicago
Chicago, Illinois, United States
Sara Reagan, BS
Clinical Research Coordinator
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Jane Gillham, PhD
Professor
Swarthmore College
Swarthmore, Pennsylvania, United States
Jami Young, Ph.D. (she/her/hers)
Professor
Childrens Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Background: There is currently a global youth mental health crisis. Research indicates growing levels of psychological distress among adolescents, partially attributable to the circumstances surrounding COVID-19 and its aftermath. Elevated psychopathology symptoms during adolescence are linked to a host of negative psychosocial outcomes. Adolescents spend most of their waking hours at school. As such, schools have been identified as a promising setting in which to address student mental health needs. The present study reports on levels of student psychological distress identified by depression screening and a diagnostic interview conducted as part of a school-based depression prevention trial. We compare current levels of mental health difficulties among this sample to those identified in previous school-based prevention trials that used identical measures.
Methods: 536 adolescents (14-17 years) completed a depression screener (Center for Epidemiologic Studies Depression Scale) at school during the 2021 through 2023 academic years. Students with elevated depression symptoms (n = 275) who agreed to participate in the larger prevention study completed a diagnostic evaluation (Schedule for Affective Disorders and Schizophrenia for School Aged Children) to confirm eligibility. School counselors and administrators (n = 28) completed qualitative interviews about student mental health and school-based prevention.
Results: 69% of students screened (n = 370) endorsed elevated depression symptoms (CES-D > 16) and 12% (n = 63) reported high symptom levels (CES-D > 40), warranting a clinical interview to assess for safety. Nine percent of students who completed a diagnostic evaluation reported active suicidal ideation and/or a recent suicide attempt, and 25% of students enrolled in the trial met criteria for a depression diagnosis. These rates are considerably higher than those reported in our previous school-based prevention trials. Qualitative data converged with these quantitative findings such that school personnel expressed growing concerns about students' mental health and the challenges schools are facing.
Conclusions: The rate of elevated depression symptoms identified in this study is double or triple what has been reported in our prior school-based prevention trials. Youth symptom reports and the perceptions of school staff underscore the high levels of symptoms students are experiencing and the importance of schools as a critical setting for addressing youth mental health needs.